Related Experiment Video
Updated: May 8, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Evaluating gene-disease relationship strength in crystallin genes in association with pediatric cataracts
Alexander Ing1,2,3, Allison Goetsch Weisman1,4, Andy Drackley1,2,3
1Edwards Family Division of Genetics and Rare Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.
Abstract:
Introduction: Gene curation is the analysis of clinical and experimental evidence to determine the strength of relationship between specific genes and diseases. Gene curations allow for improved genetic testing analysis and downstream clinical outcomes. Although variants in crystallin genes are believed to cause about half of all non-syndromic inherited pediatric cataracts, formal gene curations have not been performed.Methods: Established and publicly available ClinGen protocols were utilized to perform curations for thirteen crystallin genes to evaluate strength of their associations with pediatric cataracts using published clinical and experimental evidence.Results: Seven genes (CRYAA, CRYAB, CRYBA1, CRYBB1, CRYBB2, CRYGC, CRYGD) scored as Definitively associated with autosomal dominant (AD) inherited pediatric cataracts. Two genes (CRYGA, CRYGS) as Moderate; and four genes have Limited support (CRYBA2, CRYBA4, CRYBB3 and CRYGB). Experimental evidence, when added to clinical evidence, increased the strength of gene-disease relationship for five genes (CRYAB from Limited to Definitive, CRYAA from Moderate to Definitive, CRYGA and CRYGS from Limited to Moderate and CRYGB from No Known Disease Relationship (given absence of clinical evidence) to Limited).Discussion: Optimization and clarification of these gene-disease relationships will improve harmonization of genetic test options (i.e., inclusion on cataract gene panels) and variant interpretation, ultimately allowing for improved clinical care.
Related Concept Videos
Genetic Lingo
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Photoreceptors and Visual Pathways
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

